⚕ Rx (Prescription Required)Oncology & Critical CareTargeted Therapies & Kinase Inhibitors

Imatinib

Active pharmaceutical substance formulated in Jan Aushadhi generic products for Oncology & Critical Care treatment.

🧴 Clinical Application

Take orally once daily (400 mg or 600 mg daily) with a meal and a full large glass of water (at least 250 mL) to minimize gastrointestinal and esophageal irritation. Swallow the tablet whole; if unable to swallow, dissolve tablet in a glass of water or apple juice and consume immediately.

⚠️ Side Effects

Common: Superficial periorbital and facial edema, lower extremity fluid retention, muscle cramps/spasms, nausea, diarrhea, fatigue, rash, transaminase elevations. Rare/Severe: Severe fluid retention (pleural/pericardial effusion, ascites), severe hepatotoxicity, gastrointestinal perforation in GIST tumors, and congestive heart failure.

🛡️ Safety Warnings

Weigh patients regularly and monitor for sudden fluid accumulation. Perform complete blood counts and liver function tests monthly. Dose reductions required in severe hepatic or renal dysfunction. Substrate of CYP3A4; avoid grapefruits and strong CYP3A4 inhibitors/inducers.

Jan Aushadhi Products containing Imatinib

Found 1 generic formulation(s) containing this active ingredient.

⚕ Rx OnlyTargeted Therapies & Kinase Inhibitors

Imatinib Mesylate Tablets 400mg

Tablets
10's

Imatinib Mesylate Tablets (400mg) is a revolutionary first-generation small-molecule protein tyrosine kinase inhibitor on the WHO Model List of Essential Medicines. It binds selectively to the ATP-binding pocket of the BCR-ABL chimeric tyrosine kinase (Philadelphia chromosome t(9;22)), locking it into an inactive conformation and terminating aberrant downstream proliferation signaling. Also potently inhibits receptor tyrosine kinases for platelet-derived growth factor (PDGFR) and stem cell factor (c-KIT / CD117). Indicated for newly diagnosed and chronic phase Philadelphia chromosome-positive Chronic Myeloid Leukemia (Ph+ CML), Ph+ Acute Lymphoblastic Leukemia (ALL), and c-KIT-positive Gastrointestinal Stromal Tumors (GIST).

₹232.03₹1027.2777% saved
Imatinib

Brand Equivalents & Price Comparison

Compare Jan Aushadhi generic prices against popular commercial brands for Imatinib.

Generic FormulationPack SizeJan Aushadhi PriceCommercial Brand EquivalentsAvg. Commercial PriceSavings
Imatinib Mesylate Tablets 400mg10's₹232.03IMATIB, VEENAT, IMAT, GLIVEC, IBATKIN₹1027.2777% Save

Frequently Asked Questions (FAQ)

Get answers to common queries about Imatinib generics.

How many Jan Aushadhi products contain Imatinib?＋
This directory currently lists 1 Jan Aushadhi generic product(s) containing Imatinib as an active pharmaceutical ingredient (API). The count reflects the July 2026 PMBI catalog snapshot.
Does Imatinib require a prescription at Jan Aushadhi Kendras?＋
Yes. Imatinib is classified as a prescription-required (Rx) ingredient under applicable Indian drug schedules. You must present a valid prescription from a registered medical practitioner to obtain it at a Jan Aushadhi Kendra.
What is the lowest listed price for Imatinib at Jan Aushadhi?＋
Based on the July 2026 PMBI catalog, the lowest listed MRP for a Imatinib formulation is ₹232.03. Individual prices vary by pack size and dosage form. Use the product links above for the exact MRP of each formulation.
Are Jan Aushadhi Imatinib products clinically equivalent to branded versions?＋
Jan Aushadhi generics contain the same declared active pharmaceutical ingredient (Imatinib) at the same concentration as branded counterparts and must meet CDSCO quality standards. However, inactive excipients, release mechanisms, and manufacturing processes can differ between manufacturers. Never switch a prescribed medicine without consulting your doctor.
Find a Jan Aushadhi Kendra Near You
Search 21,118 listed government pharmacies across India by PIN code. Find Imatinib products at government prices.
Search Kendras